HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
van den Kerkhof, TL
- Contributor
-
Euler, Z.
van Gils, MJ
Boeser-Nunnink, BD
Verwer, NL
Schuitemaker, H.
Sanders, RW
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P52
- URN
-
urn:nbn:de:1111-2016080726541
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van den Kerkhof, TL
- Euler, Z.
- van Gils, MJ
- Boeser-Nunnink, BD
- Verwer, NL
- Schuitemaker, H.
- Sanders, RW
- SpringerLink (Online service)
Other Objects (12)
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression
P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
HIV-1 immune escape and neutralizing antibodies : solid phase proteoliposomes containing HIV-1 envelope glycoproteins as antigens and immunogens and HIV-1 core envelope glycoproteins deficient in T-helper epitopes
HIV-1 immune escape and neutralizing antibodies : solid phase proteoliposomes containing HIV-1 envelope glycoproteins as antigens and immunogens and HIV-1 core envelope glycoproteins deficient in T-helper epitopes
Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression
P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
HIV-1 immune escape and neutralizing antibodies : solid phase proteoliposomes containing HIV-1 envelope glycoproteins as antigens and immunogens and HIV-1 core envelope glycoproteins deficient in T-helper epitopes
HIV-1 immune escape and neutralizing antibodies : solid phase proteoliposomes containing HIV-1 envelope glycoproteins as antigens and immunogens and HIV-1 core envelope glycoproteins deficient in T-helper epitopes
Cross-reactive Anti-gp41 HIV-1 Neutralizing Human Monoclonal Antibodies Selected by Competitive Panning Against gp140 – an Update
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Identification of HIV-1 neutralizing antibodies using cell surface-expressed HIV-1 envelope protein
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression
P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
HIV-1 immune escape and neutralizing antibodies : solid phase proteoliposomes containing HIV-1 envelope glycoproteins as antigens and immunogens and HIV-1 core envelope glycoproteins deficient in T-helper epitopes
HIV-1 immune escape and neutralizing antibodies : solid phase proteoliposomes containing HIV-1 envelope glycoproteins as antigens and immunogens and HIV-1 core envelope glycoproteins deficient in T-helper epitopes